Jnj Net Worth (Updated 2025).

Johnson & Johnson, often simply referred to as J&J, began its journey in 1886 when three brothers, Robert, James, and Edward Johnson, decided to go into business together. The company was founded on the principles of Caring, Quality, and Respect, values that still guide J&J today. The Johnson brothers started with a single product, sterile surgical dressings, which they sold door-to-door, marking the humble beginning of what would become one of the world’s largest and most respected healthcare companies.

J&J’s breakthrough into fame came with the introduction of its first mass-market product, Johnson’s Baby Powder, in 1894. The powder’s purity and gentle formula made it a hit among parents, and it quickly became a staple in households across the United States. This success allowed J&J to expand its product offerings and enter new markets, solidifying its position as a leading consumer healthcare company.

Johnson & Johnson’s Net Worth in 2025

As of the latest available information, Johnson & Johnson’s net worth in 2025 is estimated to be around $475 billion.

Career

Johnson & Johnson, often referred to as J&J, is an American multinational corporation founded in 1886. It operates in the medical devices, pharmaceuticals, and consumer packaged goods sectors. With a rich history of innovation, J&J has been a pioneer in numerous healthcare advancements, including the development of Band-Aids, Tylenol, and the five-day measles vaccine.

Other Ventures

Beyond its core businesses, J&J has ventured into various initiatives. It has a significant presence in emerging markets, with operations in over 60 countries. The company also invests in research and development, with a focus on areas like immunology, neuroscience, and cardiovascular diseases. Additionally, J&J has made strategic acquisitions and partnerships to expand its portfolio and maintain its competitive edge.

Assets

As of 2021, J&J’s total assets were valued at approximately $191.1 billion. This includes current assets like cash and investments, as well as non-current assets such as property, plant, and equipment, and goodwill. The company’s extensive global network of manufacturing facilities and distribution centers also contributes to its overall asset value.

Annual Income

In 2021, J&J reported total revenue of $93.8 billion, marking a 10.8% increase from the previous year. The company’s pharmaceutical segment was its largest contributor, generating $57.6 billion in sales. The medical devices and consumer health segments brought in $27.2 billion and $7.2 billion, respectively. Despite facing challenges like the COVID-19 pandemic, J&J has demonstrated resilience and continued growth in its annual income.

Frequently Asked Questions about  Jnj

**

Frequently Asked Questions: J&J Net Worth

**

**

1. What is the net worth of J&J?

**

As of the latest estimates, the net worth of Johnson & Johnson (J&J) is approximately $460 billion.

**

2. How does J&J generate its revenue?

**

J&J generates revenue through its three main business segments: Consumer Health, Pharmaceuticals, and Medical Devices. These segments offer a wide range of products and services, including consumer health products, pharmaceuticals, and medical devices.

**

3. What are some of J&J’s most popular products?

**

Some of J&J’s most popular products include consumer health brands like Tylenol, Aveeno, and Listerine, pharmaceuticals such as Remicade and Stelara, and medical devices like DePuy Synthes and Ethicon products.

**

4. Who is the CEO of J&J?

**

Joaquin Duato is the current CEO of Johnson & Johnson. He succeeded Alex Gorsky in January 2022.

**

5. When was J&J founded?

**

J&J was founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson.

**

6. Where is J&J headquartered?

**

J&J’s global headquarters is located in New Brunswick, New Jersey, USA.

**

7. How many employees does J&J have?

**

As of 2021, J&J employs approximately 130,000 people worldwide.

**

8. What is J&J’s stock symbol?

**

J&J’s stock symbol is ‘JNJ’ and it is listed on the New York Stock Exchange (NYSE).

**

9. How has J&J performed in the stock market recently?

**

J&J’s stock performance has been relatively stable over the past few years, with a slight increase in its stock price. However, it has experienced fluctuations due to various factors, including market conditions and company-specific events.

**

10. What are some of J&J’s recent acquisitions?

**

Some of J&J’s recent acquisitions include the purchase of Ablynx, a Belgian biopharmaceutical company, in 2018, and the acquisition of Lifescan, a diabetes care company, in 2021. J&J has also made several strategic investments and partnerships in recent years to strengthen its product pipeline and expand its business.